Acetylsalicylic acid Completed Phase 4 Trials for Platelet Aggregation / Coronary Artery Disease (CAD) / Platelet Transcriptome Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01815008Pharmacogenomics of Antiplatelet Response - I